Plague Vaccine or Diagnostics
- 技術優勢
- A vaccine developed with this technology will target a surface protein required for the virulence of Yersinia pestis and is non-pathogenic
- 技術應用
- Vaccine development against plague; adjuvant to enhance immunogenicity in a vaccine; detection and diagnosis of plague infection
- 詳細技術說明
- This patented technology exploits one of the proteins composing the pathogenic structure of Yersinia pestis. The recombinant protein or its derivatives can be used as an antigen to develop a novel vaccine for immunization against the plague.
- *Abstract
-
This technology relates to recombinant protein products that are useful as antigens for development of antibody in a plague diagnostics or vaccine preparation.
- 國家/地區
- 美國
欲了解更多信息，請點擊 這裡
